Search

everythinglearnresearchcommunity

for

Search:↓

Generalized vitiligo in Chinese patients is linked to other autoimmune diseases, especially in familial cases.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Hair follicles could help develop eye treatments by studying immune responses.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Amniotic allograft may be more effective than platelet-rich plasma for midface aging treatment.

Combined prednisone and cyclosporine therapy led to excellent hair regrowth and improved well-being.

Phototherapy can help treat hair loss in alopecia areata.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Honokiol from Magnolia plants may be beneficial for treating various skin conditions and promoting hair growth.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Combining stem cell-conditioned media with anti-androgen drugs can improve hair growth in male pattern baldness.

OR-101 shows promise for treating alopecia areata by improving hair growth.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.